In short. Dermatology diagnoses well and controls well; it erases less well. Where the boundary sits, why treatment takes months, and how to recognise advice that overpromises.

Key points

  • Topical treatment for an inflammatory condition usually needs several weeks before its full effect can be judged, and systemic treatment often longer.
  • A fair trial is measured in weeks to a few months.
  • Anyone offering a verdict after three days, in either direction, is not giving you useful information.

Dermatology is good at some things and poor at others, and a great deal of disappointment in skin care comes from asking it to do something it cannot. This page sets out, as plainly as possible, where the boundary sits.

What dermatology does well

Diagnosis is the specialty’s strength. Most skin disease can be named accurately, and where it cannot, a scraping, a patch test, a blood test or a biopsy usually supplies the answer. Infection is treated effectively and often cured outright. Inflammatory disease — eczema, psoriasis, urticaria — is controlled well enough that most patients can expect long stretches of quiet skin. Skin cancer found early is among the most curable of all cancers.

What it does less well

It rarely cures chronic disease. Eczema, psoriasis, vitiligo, chronic urticaria, cutaneous lupus and blistering disease are managed rather than eliminated, and they relapse when treatment stops. It reverses scarring poorly: once skin has scarred or hair follicles have been destroyed, treatment can improve appearance but cannot restore what was lost. It removes pigment unevenly, and pigmentation frequently returns after sun exposure. It cannot make an inherited tendency go away.

Timescales, honestly stated

Topical treatment for an inflammatory condition usually needs several weeks before its full effect can be judged, and systemic treatment often longer. A fair trial is measured in weeks to a few months. Anyone offering a verdict after three days, in either direction, is not giving you useful information.

Risk is part of treatment

Effective medicines have side effects, and the more effective the medicine the more that tends to be true. Topical corticosteroids used long-term and unsupervised thin the skin. Systemic immunosuppressants and biologic agents require blood tests, and they increase susceptibility to some infections. None of that makes treatment a bad idea; it makes monitoring a necessary part of it.

What medicine cannot promise

Nobody can promise that a chronic rash will never return, that a scar will disappear, or that treatment will be free of side effects. The honest offer is narrower and more useful: an accurate diagnosis, a plan that reflects the evidence, a clear statement of what is likely and what is not, and follow-up that adjusts the plan as the disease changes.

Be cautious of any clinic that

  • Guarantees a cure, a specific result or a fixed timescale for a chronic skin disease.
  • Sells a single product or device as the answer to unrelated skin problems.
  • Will not say what the diagnosis is, or what will happen if the treatment is not used.

Related reading

Frequently asked questions

What does dermatology do well?

Diagnosis is the specialty’s strength, and where a condition cannot be named from the examination a scraping, patch test, blood test or biopsy usually supplies the answer. Infection is treated effectively and often cured outright, and skin cancer found early is among the most curable of all cancers.

What does dermatology do less well?

It rarely cures chronic disease. Eczema, psoriasis, vitiligo, chronic urticaria, cutaneous lupus and blistering disease are managed rather than eliminated and relapse when treatment stops. It reverses scarring poorly, removes pigment unevenly, and cannot make an inherited tendency go away.

How long is a fair trial of skin treatment?

Topical treatment for an inflammatory condition usually needs several weeks before its full effect can be judged, and systemic treatment often longer. A fair trial is measured in weeks to a few months, so anyone offering a verdict after three days is not giving useful information.

Risks & Limitations

  • Most chronic skin disease is managed rather than cured, and relapse is expected.
  • Treatments typically need 8–12 weeks before response can be judged fairly.
  • Topical treatment can cause irritation, dryness, peeling and photosensitivity.
  • Systemic therapy may require blood monitoring and carries organ, metabolic and pregnancy risks.
  • Isotretinoin in particular requires strict monitoring and pregnancy prevention.
  • Pigment change is often slow and may be incomplete.
  • No treatment works for everyone, and response cannot be predicted with certainty.

When to Seek Care

  • A mole or lesion that changes in size, shape or colour, or starts to bleed, itch or crust.
  • Fever with a widespread rash, blistering, or rash involving the eyes, mouth or genitals — seek emergency care.
  • Rapidly spreading redness, swelling or pain in the skin.
  • Facial swelling or difficulty breathing — possible severe reaction; seek emergency care immediately.
  • New or worsening symptoms while taking a monitored medication.

References & Further Reading

  • American Academy of Dermatology (AAD) — public and clinical guidance
  • World Health Organization (WHO) — skin and infectious disease resources
  • Chinese Medical Association, Dermatology Branch — clinical guidance
  • Cochrane Library — systematic reviews in dermatology

Medically reviewed by Yongbo Jia, MD (贾勇波), Deputy Director & Head of Dermatology. Last reviewed: 18 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.